Australia
# |
Name |
Free Cash Flow Yield |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
22.00% |
Feb. 5, 2025 | USD 2.33 | 0.08% |
|
Australia |
|
2 |
7.24% |
Feb. 5, 2025 | USD 0.74 | 0.62% |
|
Australia |
|
3 |
5.76% |
Feb. 5, 2025 | USD 7.27 | 0.71% |
|
Australia |
|
4 |
3.74% |
Feb. 5, 2025 | USD 0.74 | 1.48% |
|
Australia |
|
5 |
1.82% |
Feb. 5, 2025 | USD 169.95 | -0.56% |
|
Australia |
|
6 |
0.15% |
Feb. 5, 2025 | USD 18.33 | -0.84% |
|
Australia |
|
7 |
0.06% |
Feb. 5, 2025 | USD 1.23 | -0.40% |
|
Australia |
|
8 |
-2.08% |
Feb. 5, 2025 | USD 1.90 | -4.74% |
|
Australia |
|
9 |
-3.81% |
Feb. 5, 2025 | USD 2.46 | 10.79% |
|
Australia |
|
10 |
-16.38% |
Feb. 5, 2025 | USD 6.16 | 2.82% |
|
Australia |
The Clinical Trials company in Australia with the highest Free Cash Flow Yield is Australian Clinical Labs Limited (ASX: ACL.AX) at 22.00%.
The Clinical Trials company in Australia with the lowest Free Cash Flow Yield is Anteris Technologies Ltd (ASX: AVR.AX) at -16.38%.
The top 10 Clinical Trials companies in Australia by Free Cash Flow Yield are Australian Clinical Labs Limited, Monash IVF Group Limited, Clinuvel Pharmaceuticals Limited, Cogstate Limited, CSL Limited, Telix Pharmaceuticals Limited, PolyNovo Limited, Mesoblast Limited, Clarity Pharmaceuticals Ltd and Anteris Technologies Ltd.
The bottom 10 Clinical Trials companies in Australia by Free Cash Flow Yield are Anteris Technologies Ltd, Clarity Pharmaceuticals Ltd, Mesoblast Limited, PolyNovo Limited, Telix Pharmaceuticals Limited, CSL Limited, Cogstate Limited, Clinuvel Pharmaceuticals Limited, Monash IVF Group Limited and Australian Clinical Labs Limited.